Gilbert H Kliman's Net Worth

$887 Million

Who is Gilbert H Kliman?

Gilbert H Kliman has an estimated net worth of $887 Million. This is based on reported shares across multiple companies, which include AVEDRO INC, TESARO, Inc., EnteroMedics Inc, Doximity, Inc., ANESIVA, INC., Invuity, Inc., Trius Therapeutics Inc, INTRALASE CORP, PMV Pharmaceuticals, Inc., GLAUKOS Corp, MACROGENICS INC, Braze, Inc., Eiger BioPharmaceuticals, Inc., Carbylan Therapeutics, Inc., STAAR SURGICAL CO, Marketo, Inc., OBALON THERAPEUTICS INC, Venus Concept Inc., APPLIED GENETIC TECHNOLOGIES CORP, Transcept Pharmaceuticals Inc, EPOCRATES INC, MYOGEN INC, and METABASIS THERAPEUTICS INC.

SEC CIK

Gilbert H Kliman's CIK is 0001293171

Past Insider Trading and Trends

2014 was Gilbert H Kliman's most active year for acquiring shares with 35 total transactions. Gilbert H Kliman's most active month to acquire stocks was the month of May. 2014 was Gilbert H Kliman's most active year for disposing of shares, totalling 32 transactions. Gilbert H Kliman's most active month to dispose stocks was the month of April. 2007 saw Gilbert H Kliman paying a total of $9,500,001.45 for 3,522,070 shares, this is the most they've acquired in one year. In 2021 Gilbert H Kliman cashed out on 63,159,883 shares for a total of $175,855,337.50, their largest year based on trade value.